지연성 운동장애 치료 시장 보고서(2026년)

Tardive dyskinesia treatment involves medical management and therapeutic interventions aimed at reducing or controlling the involuntary, repetitive movements that result from long-term use of dopamine receptor-blocking agents, particularly antipsychotics.

The main treatment types for tardive dyskinesia include medications, botulinum toxin injections, deep brain stimulation, and other therapies. Medications are drugs specifically used to manage and reduce the involuntary movements associated with prolonged antipsychotic use, with commonly prescribed options including valbenazine, amantadine, tetrabenazine, and clonazepam. These treatments are administered via oral, injectable, or transdermal routes. They are distributed through channels such as hospital and retail pharmacies and are used by end users including hospitals, specialty clinics, and other healthcare providers.

Tariffs have impacted the tardive dyskinesia treatment market by increasing costs for imported medications, botulinum toxins, and medical devices used in deep brain stimulation. Hospital pharmacies, specialty clinics, and regions such as North America and Europe that rely on imports are most affected. While tariffs have raised treatment costs and slowed supply chains, they have also driven local manufacturing initiatives, promoted innovation in therapies, and encouraged diversification of treatment options.

The tardive dyskinesia treatment market research report is one of a series of new reports from The Business Research Company that provides tardive dyskinesia treatment market statistics, including tardive dyskinesia treatment industry global market size, regional shares, competitors with a tardive dyskinesia treatment market share, detailed tardive dyskinesia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tardive dyskinesia treatment industry. This tardive dyskinesia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tardive dyskinesia treatment market size has grown strongly in recent years. It will grow from $2.61 billion in 2025 to $2.84 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to prolonged use of antipsychotic medications, increasing awareness of tardive dyskinesia, limited availability of specialized treatment options, rising mental health disorder prevalence, growing hospital neurology departments.

The tardive dyskinesia treatment market size is expected to see strong growth in the next few years. It will grow to $3.9 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to development of novel dopamine-depleting therapies, expansion of deep brain stimulation adoption, increasing botulinum toxin applications, integration of telemedicine for movement disorder management, rising investment in patient-specific rehabilitation and cognitive therapies. Major trends in the forecast period include increasing adoption of dopamine-depleting agents and anticholinergic medications, rising preference for botulinum toxin injections for focal dyskinesia, growth in use of deep brain stimulation for refractory tardive dyskinesia, expansion of customized injection protocols and multi-target dbs approaches, integration of cognitive behavioral therapy and supportive rehabilitation programs.

The mounting prevalence of psychiatric disorders is poised to drive the tardive dyskinesia treatment market forward. Psychiatric disorders encompass diverse mental health issues impacting mood, cognition, conduct, and daily performance, typically needing professional evaluation and intervention. Their uptick arises from escalating stress and lifestyle strains like heavy workloads, social disconnection, and scant self-care time. Tardive dyskinesia treatment curbs uncontrolled motions, boosting therapy success and life quality for those on extended antipsychotics. For example, in November 2023, NHS England, a UK public health authority, found probable mental disorders in 20.3% of 8-16-year-olds, 23.3% of 17-19-year-olds, and 21.7% of 20-25-year-olds. Thus, the rising psychiatric disorders are fueling the tardive dyskinesia treatment market.

Leading companies in the tardive dyskinesia treatment market are advancing novel drugs like sprinkle capsule formulations to boost compliance for those with swallowing challenges. Sprinkle capsule formulations let users open capsules and mix contents into soft foods, simplifying intake for dysphagia sufferers. For instance, in July 2024, Neurocrine Biosciences Inc., a US biotech firm, rolled out Ingrezza sprinkle (valbenazine) capsules, the top vesicular monoamine transporter 2 (VMAT2) inhibitor for adults with tardive dyskinesia and Huntington's chorea. This daily oral option balances brain dopamine to tame involuntary movements, with a sprinkle design aiding hard-to-swallow cases.

In April 2025, Johnson & Johnson, a US pharma powerhouse, acquired Intra-Cellular Therapies for an undisclosed sum. This bolsters Johnson & Johnson's neuroscience dominance and foothold in booming mental health therapies. Intra-Cellular Therapies Inc. is a US pharma specialist in tardive dyskinesia solutions.

Major companies operating in the tardive dyskinesia treatment market are AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, Adamas Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation.

North America was the largest region in the tardive dyskinesia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tardive dyskinesia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tardive dyskinesia treatment market includes revenues earned by entities through botulinum toxin injection services, deep brain stimulation procedures, and diagnostic and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tardive Dyskinesia Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tardive dyskinesia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tardive dyskinesia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tardive dyskinesia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment Type: Medications; Botulinum Toxin Injections; Deep Brain Stimulation; Other Treatment Types
• 2) By Drug: Valbenazine; Amantadine; Tetrabenazine; Clonazepam; Other Drugs
• 3) By Route Of Administration: Oral Administration; Injection; Transdermal Patches
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Medications: Antipsychotic Medications; Benzodiazepines; Dopamine-Depleting Agents; Anticholinergic Agents
• 2) By Botulinum Toxin Injections: Facial Muscle Injections; Neck Muscle Injections; Limb Muscle Injections; Customized Injection Protocols
• 3) By Deep Brain Stimulation: Subthalamic Nucleus Stimulation; Globus Pallidus Interna Stimulation; Thalamic Stimulation; Multi-Target Stimulation
• 4) By Other Treatment Types: Supportive Therapies; Cognitive Behavioral Therapy; Physical Rehabilitation; Emerging Experimental Treatments
• Companies Mentioned: AbbVie Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Limited; Otsuka Pharmaceutical Co. Ltd.; Jazz Pharmaceuticals plc; Kyowa Kirin Co Ltd.; H. Lundbeck A/S; Neurocrine Biosciences Inc.; Acadia Pharmaceuticals Inc.; Upsher-Smith Laboratories LLC; Adamas Pharmaceuticals Inc.; Sunovion Pharmaceuticals Inc.; Mitsubishi Tanabe Pharma Corporation.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Tardive Dyskinesia Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Tardive Dyskinesia Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Tardive Dyskinesia Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Tardive Dyskinesia Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Dopamine-Depleting Agents And Anticholinergic Medications
  • 4.2.2 Rising Preference For Botulinum Toxin Injections For Focal Dyskinesia
  • 4.2.3 Growth In Use Of Deep Brain Stimulation For Refractory Tardive Dyskinesia
  • 4.2.4 Expansion Of Customized Injection Protocols And Multi-Target DBS Approaches
  • 4.2.5 Integration Of Cognitive Behavioral Therapy And Supportive Rehabilitation Programs

5. Tardive Dyskinesia Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Neurology Centers
• 5.4 Rehabilitation Centers
• 5.5 Research & Diagnostic Centers

6. Tardive Dyskinesia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tardive Dyskinesia Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Tardive Dyskinesia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Tardive Dyskinesia Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Tardive Dyskinesia Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Tardive Dyskinesia Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tardive Dyskinesia Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tardive Dyskinesia Treatment Market Segmentation

• 9.1. Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types
• 9.2. Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs
• 9.3. Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Administration, Injection, Transdermal Patches
• 9.4. Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
• 9.5. Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Specialty Clinics, Other End-Users
• 9.6. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antipsychotic Medications, Benzodiazepines, Dopamine-Depleting Agents, Anticholinergic Agents
• 9.7. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Facial Muscle Injections, Neck Muscle Injections, Limb Muscle Injections, Customized Injection Protocols
• 9.8. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Subthalamic Nucleus Stimulation, Globus Pallidus Interna Stimulation, Thalamic Stimulation, Multi-Target Stimulation
• 9.9. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Supportive Therapies, Cognitive Behavioral Therapy, Physical Rehabilitation, Emerging Experimental Treatments

10. Tardive Dyskinesia Treatment Market Regional And Country Analysis

• 10.1. Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tardive Dyskinesia Treatment Market

• 11.1. Asia-Pacific Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tardive Dyskinesia Treatment Market

• 12.1. China Tardive Dyskinesia Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tardive Dyskinesia Treatment Market

• 13.1. India Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tardive Dyskinesia Treatment Market

• 14.1. Japan Tardive Dyskinesia Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tardive Dyskinesia Treatment Market

• 15.1. Australia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tardive Dyskinesia Treatment Market

• 16.1. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tardive Dyskinesia Treatment Market

• 17.1. South Korea Tardive Dyskinesia Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tardive Dyskinesia Treatment Market

• 18.1. Taiwan Tardive Dyskinesia Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tardive Dyskinesia Treatment Market

• 19.1. South East Asia Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tardive Dyskinesia Treatment Market

• 20.1. Western Europe Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tardive Dyskinesia Treatment Market

• 21.1. UK Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tardive Dyskinesia Treatment Market

• 22.1. Germany Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tardive Dyskinesia Treatment Market

• 23.1. France Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tardive Dyskinesia Treatment Market

• 24.1. Italy Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tardive Dyskinesia Treatment Market

• 25.1. Spain Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tardive Dyskinesia Treatment Market

• 26.1. Eastern Europe Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tardive Dyskinesia Treatment Market

• 27.1. Russia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tardive Dyskinesia Treatment Market

• 28.1. North America Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tardive Dyskinesia Treatment Market

• 29.1. USA Tardive Dyskinesia Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tardive Dyskinesia Treatment Market

• 30.1. Canada Tardive Dyskinesia Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tardive Dyskinesia Treatment Market

• 31.1. South America Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tardive Dyskinesia Treatment Market

• 32.1. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tardive Dyskinesia Treatment Market

• 33.1. Middle East Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tardive Dyskinesia Treatment Market

• 34.1. Africa Tardive Dyskinesia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Segmentation By Drug, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tardive Dyskinesia Treatment Market Regulatory and Investment Landscape

36. Tardive Dyskinesia Treatment Market Competitive Landscape And Company Profiles

• 36.1. Tardive Dyskinesia Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Tardive Dyskinesia Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Tardive Dyskinesia Treatment Market Company Profiles
  • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

37. Tardive Dyskinesia Treatment Market Other Major And Innovative Companies

• Kyowa Kirin Co Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, Adamas Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation

38. Global Tardive Dyskinesia Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tardive Dyskinesia Treatment Market

40. Tardive Dyskinesia Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Tardive Dyskinesia Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Tardive Dyskinesia Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Tardive Dyskinesia Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer